S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Actualizaciones en tiempo real para Actinogen Medical Ltd [ACW.AX]

Bolsa: ASX Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización3 may 2024 @ 01:52

-15.79% $ 0.0320

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 01:52):
Profile picture for Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia...

Stats
Volumen de hoy 6.16M
Volumen promedio 2.99M
Capitalización de mercado 74.46M
EPS $0 ( 2024-02-26 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -3.20
ATR14 $0 (0.00%)

Actinogen Medical Ltd Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Actinogen Medical Ltd Finanzas

Annual 2023
Ingresos: $4.89M
Beneficio Bruto: $4.48M (91.70 %)
EPS: $-0.00570
FY 2023
Ingresos: $4.89M
Beneficio Bruto: $4.48M (91.70 %)
EPS: $-0.00570
FY 2022
Ingresos: $3.64M
Beneficio Bruto: $3.24M (88.99 %)
EPS: $-0.00530
FY 2021
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.00280

Financial Reports:

No articles found.

Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico